在FDA不良药物事件报告系统数据库中使用不成比例性分析对奥马利祖马布的现实世界药监测研究
Yongfu Song1, Zhuang Wang1, Na Wang1
1College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, 130117, Jilin, China.
这项研究分析了奥马利祖马布的真实安全数据,揭示了常见和未列出的不良事件,如过敏反应和喘危机. 这些发现突显了奥马利祖马布副作用的性别和年龄差异.
科学领域:
- 药物监督 药物监督 药物监督
- 现实世界的证据.
- 生物疗法 生物疗法
背景情况:
- 奥马利祖马布有效治疗喘和疹等过敏症.
- 现有的安全数据依赖于有限的临床试验.
- 现实世界的安全评估对于更广泛的应用至关重要.
研究的目的:
- 综合评估奥马利祖马布 (omalizumab) 的现实安全情况.
- 使用大型数据库识别与奥马利祖马布相关的不良药物事件 (ADEs).
- 分析与奥马利祖马布相关的ADEs的人口差异.
主要方法:
- 使用了美国食品和药物管理局的不良事件报告系统 (FAERS) 数据库 (2004-2024).
- 采用了四种不成比例分析方法来评估ADE的意义.
- 分析了跨性别和年龄子组的ADEs.
主要成果:
- 确定了49456份与奥马利祖马布相关的不良事件报告,在27个器官类别中发现了357个特定的不良事件.
- 已确认的已知风险 (过敏反应,喘) 和已确定未列出的事件 (喘危机,下呼吸道拥堵).
- 观察到与奥马利祖马布相关的不良事件存在显著的性别和年龄差异,中位数发病时间为145天.
结论:
- 奥马利祖马布与列出的和未列出的不良事件有关,包括严重反应.
- 现实世界的数据揭示了奥马利祖马布安全性的显著人口差异.
- 研究结果支持在临床实践中优化奥马利祖马布的使用,提高疗效,并尽量减少副作用.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Analysis of Population Pharmacokinetic Data
Quantitative Aspects of Drug-Receptor Interaction
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
